menu
    • menu

    Company profile for Siegfried AG

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceut...
    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceutical company, Siegfried is now one of the few suppliers who can develop both active ingredients and ready-made drugs under one roof. This combination of experience and know-how is unique in the CDMO market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Siegfried AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Untere Bruehlstrasse 4, 4800 Zofingen
    Telephone
    Telephone
    +41 62 746 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.siegfried.ch/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/siegfried-holding-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/siegfried_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    “Translational Pharmaceutics, our flagship platform for drug development, empowers our clients with unparalleled flexibility”

    This week, SpeakPharma interviews Denise Sutton, Chief Operating Officer and Site Head at Quotient Sciences’ Nottingham facility in the UK. Quotient Sciences is a drug development and manufacturing accelerator that offers the innovative Translational Pharmaceutics platform to support customers in overcoming drug development challenges. Sutton has been with the company for over 25 years. In this interview, she provides insights into the evolution of Quotient Sciences’ Nottingham facility and discusses how the organization has transformed from a small 10-bed clinic to a comprehensive drug development campus with six GMP suites. She also shares her perspective on the company’s unique approach to integrating drug development services. HIGHLIGHTS// evolution of Quotient Sciences’ Nottingham facility/ unique approach to integrating drug development services How has the Nottingham site transformed from when it was founded, to what it is today? Initially, we were a small company with fewer than 50 employees, a 10-bed clinic, and a single lab. Over 90 percent of our work focused on gamma scintigraphic imaging (a diagnostic test that creates images of the body’s internal organs and tissues using gamma rays). Due to the short half-life radionuclides we used to label dosage forms, every product we manufactured had a limited time to be dosed. At the end of 1999, we moved our headquarters to a purpose-built, two-storey facility—now known as Trent House on our now much larger Nottingham campus. We built three good manufacturing practice (GMP) suites on the top floor and three clinical wards on the bottom floor. These were very early days that marked the start of our Translational Pharmaceutics platform. We continued to expand the range of scintigraphy applications we offered in response to changing customer requirements until, in 2008, when we approached the MHRA (UK’s Medicines and Healthcare products Regulatory Agency) with a new request. We asked if it might be possible to work at the same pace as we did in our scintigraphic imaging studies, but do so for conventional drug development, without the radiolabel. We explored the application of ICH Q8 Quality by Design (QbD) guidelines to introduce a compositional design space into the CMC section of our regulatory dossier. This officially created a methodology for applying the Translational Pharmaceutics platform, and we haven't looked back since. Today, we have expanded substantially. Our Nottingham site is a campus of five buildings. We have development and analytical labs, six GMP suites, six clinical wards with a total of 85 beds (where we conduct healthy volunteer phase 1 clinical studies), and many talented colleagues covering our spectrum of CRO and CDMO services. HIGHLIGHTS// officially created a methodology for applying the Translational Pharmaceutics platform/ development and analytical labs/ six GMP suites   How is Translational Pharmaceutics applied to drug development programs? We apply Translational Pharmaceutics across three core applications: first-in-human clinical studies, drug product optimization programs through rapid formulation development and clinical testing, and as a part of human ADME (absorption, distribution, metabolism, and excretion) programs. No matter how a client chooses to work with us to apply Translational Pharmaceutics, the benefits of using a single organization and project management team to integrate services lets our clients remain in control and one step ahead of the emerging data that impacts the success of their molecule. Over all these years, our flagship Translational Pharmaceutics platform for drug development has remained unchanged in the way it empowers our customers and offers them unparalleled flexibility. HIGHLIGHTS// three core applications/ benefits of using a single organization/ clients remain in control   What would you say are the key strengths of Quotient Sciences’ Nottingham site? How do you support customer programs? Nowhere else would a single project manager oversee such a broad spectrum of activities, let alone be expected to ensure seamless, timely progression across functions that in any other company (i.e. at other CDMOs or CROs) would be delivered through multiple operating areas or through the use of a combination of third-party vendors. The project managers do face challenges. But by working with the project team, they are able to anticipate, avoid, and mitigate any impact whenever necessary. We know that time is incredibly valuable for our customers. A project Gantt chart is our project management team’s guiding light. I believe our project management team is truly world-leading – they communicate well, show great compassion, and lead with integrity. I’m super proud of our high-performing, supportive, cross-functional teams that support our customers when they trust their molecules to us, and work collaboratively to deliver the best possible service. After 25 years at Quotient, I continue to really enjoy going to work. I am indebted to various colleagues for helping me continue to feel this way. HIGHLIGHTS// project management team is truly world-leading/ high-performing, supportive, cross-functional teams/ 25 years at Quotient  

    Impressions: 5049

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility

    Radio Compass
    16 Dec 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    FDA okays 50 new drugs in 2024; BMS’ Cobenfy, Lilly’s Kisunla lead pack of breakthrough therapies

    FDA okays 50 new drugs in 2024; BMS’ Cobenfy, Lilly’s Kisunla lead pack of breakthrough therapies

    In 2024, the biopharma industry continued to advance on its robust trajectory of innovation. Though the US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) approved fewer drugs, there was a significant increase in medical breakthroughs.While the CDER approved 50 new drugs in 2024, as compared to 55 in 2023, the CBER granted 14 biologics approvals in 2024, down from 20 in 2023.The European Medicines Agency (EMA) approved 34 new therapies, up from 32 in 2023, while Health Canada granted 28 approvals, down from 38 in 2023.The year saw long-awaited treatments being approved in areas such as schizophrenia and Alzheimer’s disease in the second half (H2) of 2024. In H1 2024, drugs to treat metabolic dysfunction-associated steatohepatitis (MASH) and chronic obstructive pulmonary disease (COPD) had been granted FDA approvals.As the year drew to a close, FDA began approving drugs at a feverish pace, with 29 of the CDER’s 50 approvals coming in H2.Like most years, the landscape of drug approvals was dominated by oncology, with 15 of the 50 drugs (30 percent) approved targeting various forms of cancer. This was followed by dermatology and non-malignant hematology, each accounting for 12 percent of approvals. Notably, small molecules continued to dominate the market, making up for 64 percent of the new drug approvals, while 32 percent were proteins, including monoclonal and bi-specific antibodies. View New Drug Approvals in 2024 with Estimated Sales (Free Excel Available)Karuna-BMS’ schizophrenia drug, Lilly’s Alzheimer’s med, Neurocrine’s Crenessity dominate list of pathbreaking approvals in H2Out of the 50 new drugs approved in 2024, CDER identified 24 (48 percent) as first-in-class, showcasing novel mechanisms of action. The most anticipated approval of 2024 was Karuna and Bristol Myers Squibb’s Cobenfy, a groundbreaking treatment for schizophrenia. This fixed-dose combination of xanomeline and trospium chloride represents the first novel mechanism of action in decades for this debilitating psychiatric condition. Analysts forecast peak annual sales of over US$ 3.3 billion for Cobenfy. Eli Lilly’s Alzheimer’s drug Kisunla (donanemab) became the third amyloid-targeting antibody to gain FDA approval. Unlike its predecessors, Kisunla offers a unique limited-duration treatment regimen, allowing patients to discontinue therapy once amyloid levels in the brain drop below a certain threshold. Priced at approximately US$ 32,000 per year, it is positioned as a cost-effective alternative to existing treatments. Analysts estimate peak sales of US$ 2.4 billion for Kisunla.Crenessity (crinecerfont), developed by Neurocrine Biosciences, became the first FDA-approved treatment in decades for classic congenital adrenal hyperplasia (genetic conditions that affect the adrenal glands). Similarly, Vertex’s triple combination therapy of deutivacaftor, tezacaftor & vanzacaftor (Alyftrek) for cystic fibrosis represents a significant advancement in genetic disease treatment. Analysts forecast peak sales exceeding US$ 8.3 billion, underscoring the therapy’s potential to transform patient care.Meanwhile, Bridgebio’s Attruby (acoramidis hydrochloride) emerged as a promising treatment for cardiac amyloidosis, a life-threatening condition. View New Drug Approvals in 2024 with Estimated Sales (Free Excel Available) Roche’s Itovebi, Checkpoint’s Unloxcyt clinch FDA approvals in H2 2024; forecast to achieve blockbuster statusThe dominance of cancer drug approvals reflects the ongoing focus on targeted therapies, immuno-oncology, and precision medicine to improve outcomes for patients with hard-to-treat cancers.Among the year’s notable FDA approvals was Genentech’s Itovebi (inavolisib), another targeted therapy that treats hormone receptor-positive (HR+), HER2-negative breast cancer. Itovebi is a PI3Kα inhibitor designed specifically for patients with PIK3CA mutations, a common driver of resistance to endocrine therapy in breast cancer. It demonstrated a more tolerable safety profile. Roche projects Itovebi’s peak (annual) sales to reach CHF 2 billion (US$ 2.3 billion).Checkpoint Therapeutics’ Unloxcyt (cosibelimab) joined the crowded checkpoint inhibitor market as the eleventh PD-1/PD-L1-targeting monoclonal antibody approved by the FDA. It was granted approval for cutaneous squamous cell carcinoma (cSCC), an aggressive form of skin cancer with high recurrence rates. As compared to other checkpoint inhibitors, like Keytruda (pembrolizumab) and Opdivo (nivolumab), Unloxcyt is likely to offer an advantage in immune activation.FDA also approved Astellas’ Vyloy (zolbetuximab), a first-in-class monoclonal antibody for metastatic gastric and gastroesophageal junction (GEJ) adenocarcinoma. Analysts forecast peak sales of approximately US$ 850 million for Vyloy.Syndax Pharmaceuticals’ Revuforj (revumenib) was approved by FDA to treat a type of acute leukemia in both adults and children. This approval introduces a novel class of medications known as menin inhibitors. These agents are currently in clinical development for the treatment of genetically defined subsets of acute leukemia. These inhibitors function by preventing the activation of cancer growth-related proteins. View New Drug Approvals in 2024 with Estimated Sales (Free Excel Available) Potential blockbusters Lilly’s Ebglyss, Galderma’s Nemluvio lead advances in dermatologyEli Lilly’s Ebglyss (lebrikizumab) garnered significant attention. Approved by FDA for moderate-to-severe atopic dermatitis, this monoclonal antibody introduces a less burdensome dosing regimen compared to its competitors, with maintenance therapy required only once a month. This feature positions it as a potential contender to Dupixent (dupilumab), a market leader in atopic dermatitis. Ebglyss sales are forecast to reach US$ 1.9 billion by 2030.Galderma’s Nemluvio (nemolizumab) secured FDA approval for two indications in 2024 — prurigo nodularis (a chronic disorder of the skin) and moderate-to-severe atopic dermatitis in patients aged 12 years and older. As the first humanized IgG2 monoclonal antibody targeting the IL-31 receptor, Nemluvio directly inhibits the key driver of itch and inflammation in both these conditions. With its unique mechanism and broad dermatology potential, analysts forecast peak sales of approximately US$ 1.66 billion. Ebglyss and Nemluvio underscore the growing importance of biologics in dermatological care.Botanix Pharmaceuticals also made strides in dermatology by clinching an FDA approval for Sofdra (sofpironium) in June. The drug has been okayed for the treatment of primary axillary hyperhidrosis, a condition characterized by excessive sweating.Ascendis Pharma’s Yorvipath (palopegteriparatide), a therapy approved by FDA to treat hypoparathyroidism, is forecast to achieve blockbuster sales of US$ 1.8 billion by 2030, highlighting its potential to transform endocrine care. View New Drug Approvals in 2024 with Estimated Sales (Free Excel Available) Our viewOverall, 2024 was defined by its breakthrough drug approvals. The year also saw significant reduction in complete response letters (CRLs) — they dropped from 43 in 2023 to just 29 in 2024. This suggests improved industry preparedness and alignment with regulatory expectations.The new year began with the approval of Datroway (datopotamab deruxtecan) from AstraZeneca and Daiichi Sankyo, marking a significant advancement in oncology. Several other promising new drugs are coming up for FDA approval this year, such as J&J’s nipocalimab, Vertex Pharmaceuticals’ suzetrigine, Elevar Therapeutics’ rivoceranib/camrelizumab, Sanofi’s fitusiran and GSK’s gepotidacin. Hopefully, the momentum of breakthrough approvals will continue through 2025, political headwinds in the US notwithstanding. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 619

    https://www.pharmacompass.com/radio-compass-blog/fda-okays-50-new-drugs-in-2024-bms-cobenfy-lilly-s-kisunla-lead-pack-of-breakthrough-therapies

    #PharmaFlow by PHARMACOMPASS
    30 Jan 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Siegfried Confirmed in Dow Jones Sustainability Index Europe
    Siegfried Confirmed in Dow Jones Sustainability Index Europe

    23 Dec 2024

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2024-12-23/siegfried-once-again-confirmed-in-the-dow-jones-sustainability-index-europe

    PHARMAWEB
    23 Dec 2024
    Share Share
    Siegfried opens global R&D Center for Drug Substance in Switzerland
    Siegfried opens global R&D Center for Drug Substance in Switzerland

    22 Nov 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/siegfried-opens-global-rd-center-for-drug-substances-in-switzerland-16459

    INDPHARMAPOST
    22 Nov 2024
    Share Share
    Dinamiqs opens new lab in Zurich
    Dinamiqs opens new lab in Zurich

    12 Nov 2024

    // PRESS RELEASE

    https://www.siegfried.ch/dinamiqs-opens-new-lab-in-zurich/

    PRESS RELEASE
    12 Nov 2024
    Share Share
    Strategy EVOLVE+ paves the way for continued profitable growth
    Strategy EVOLVE+ paves the way for continued profitable growth

    24 Oct 2024

    // PRESS RELEASE

    https://www.siegfried.ch/strategy-evolve-paves-the-way-for-continued-profitable-growth/

    PRESS RELEASE
    24 Oct 2024
    Share Share
    EGS Beteiligungen Ups Stake In Siegfried To 7.2% Registered Shares
    EGS Beteiligungen Ups Stake In Siegfried To 7.2% Registered Shares

    04 Sep 2024

    // PRESS RELEASE

    https://www.siegfried.ch/egs-beteiligungen-ag-exercises-right-to-convert-bond-and-increases-its-shareholding-in-siegfried-to-7-2-registered-shares/

    PRESS RELEASE
    04 Sep 2024
    Share Share
    Siegfried opens new quality control lab in Minden
    Siegfried opens new quality control lab in Minden

    22 Aug 2024

    // PRESS RELEASE

    https://www.siegfried.ch/siegfried-opens-new-quality-control-lab-in-minden/

    PRESS RELEASE
    22 Aug 2024
    Share Share

    CEP/COS

    read-more
    read-more

    01

    Acemetacin

    CEP/COS

    VMX
    Not Confirmed
    arrow

    02

    Acemetacin, Code 100033

    CEP/COS

    VMX
    Not Confirmed
    arrow

    03

    Acemetacin, Polymorphic form II

    CEP/COS

    VMX
    Not Confirmed
    arrow

    04

    Amitriptyline hydrochloride

    CEP/COS

    VMX
    Not Confirmed
    arrow

    05

    Amorolfine hydrochloride

    CEP/COS

    VMX
    Not Confirmed
    arrow

    06

    Amorolfine hydrochloride, Nantong site

    CEP/COS

    VMX
    Not Confirmed
    arrow

    07

    Amylmetacresol

    CEP/COS

    VMX
    Not Confirmed
    arrow

    08

    Articaine hydrochloride

    CEP/COS

    VMX
    Not Confirmed
    arrow

    09

    Bupivacaine hydrochloride

    CEP/COS

    VMX
    Not Confirmed
    arrow

    10

    Buprenorphine

    CEP/COS

    VMX
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Packaging

    Click here to discover the service providers for Packaging

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Siegfried AG and get a quotation

    Siegfried AG is a supplier offers 190 products (APIs, Excipients or Intermediates).

    Find a price of Buprenorphine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Caffeine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dobutamine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dopamine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Mepivacaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybuprocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybutynin Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Primidone bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with CEP, JDMF offered by Siegfried AG

    Find a price of Articaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Bupivacaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbachol bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Hydromorphone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Isotretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Methadone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Phenylephrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Pseudoephedrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Ribavirin bulk with DMF, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP offered by Siegfried AG

    Find a price of Tretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Amitriptyline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Amorolfine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Methylphenidate Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Morphine Sulfate bulk with CEP offered by Siegfried AG

    Find a price of Nifedipine bulk with CEP offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Sotalol Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Acemetacin bulk with CEP offered by Siegfried AG

    Find a price of Alitretinoin bulk with DMF offered by Siegfried AG

    Find a price of Aminophylline bulk with CEP offered by Siegfried AG

    Find a price of Amobarbital Sodium bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine Aspartate bulk with DMF offered by Siegfried AG

    Find a price of Amylmetacresol bulk with CEP offered by Siegfried AG

    Find a price of Aprepitant bulk with JDMF offered by Siegfried AG

    Find a price of Benzonatate bulk with DMF offered by Siegfried AG

    Find a price of Bethanechol bulk with DMF offered by Siegfried AG

    Find a price of Bupivacaine bulk with DMF offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Butalbital bulk with DMF offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF offered by Siegfried AG

    Find a price of Carisoprodol bulk with DMF offered by Siegfried AG

    Find a price of Chlorobutanol Hemihydrate bulk with DMF offered by Siegfried AG

    Find a price of Chloroprocaine HCl bulk with DMF offered by Siegfried AG

    Find a price of Choline Salicylate bulk with DMF offered by Siegfried AG

    Find a price of Cinchocaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Codeine Phosphate bulk with DMF offered by Siegfried AG

    Find a price of Dexmethylphenidate bulk with DMF offered by Siegfried AG

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Ephedrine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Felbamate bulk with DMF offered by Siegfried AG

    Find a price of Fosinopril bulk with CEP offered by Siegfried AG

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Siegfried AG

    Find a price of Levomethadone bulk with CEP offered by Siegfried AG

    Find a price of Levonordefrin bulk with DMF offered by Siegfried AG

    Find a price of Mefloquine bulk with DMF offered by Siegfried AG

    Find a price of Methenamine Hippurate bulk with DMF offered by Siegfried AG

    Find a price of Metolazone bulk with DMF offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Naltrexone bulk with DMF offered by Siegfried AG

    Find a price of Nsc241225 bulk with JDMF offered by Siegfried AG

    Find a price of Oxiconazole Nitrate bulk with DMF offered by Siegfried AG

    Find a price of Oxybutynin bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Phenelzine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Phenobarbital bulk with DMF offered by Siegfried AG

    Find a price of Phentermine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Primidone bulk with JDMF offered by Siegfried AG

    Find a price of Proparacaine hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ritalinic Acid bulk with DMF offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk offered by Siegfried AG

    Find a price of Tetracaine bulk with CEP offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ticlopidine bulk with JDMF offered by Siegfried AG

    Find a price of Tilidine bulk with CEP offered by Siegfried AG

    Find a price of Topiramate bulk with JDMF offered by Siegfried AG

    Find a price of Trimethobenzamide HCl bulk with DMF offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of ENAMINE AMIDE bulk with DMF offered by Siegfried AG

    Find a price of Acetylcholine Chloride bulk offered by Siegfried AG

    Find a price of Acemetacin bulk offered by Siegfried AG

    Find a price of Allopurinol bulk offered by Siegfried AG

    Find a price of Alphacetylmethadol bulk offered by Siegfried AG

    Find a price of Amiloride Hydrochloride bulk offered by Siegfried AG

    Find a price of Apazone bulk offered by Siegfried AG

    Find a price of Benzomethamine bulk offered by Siegfried AG

    Find a price of Benzphetamine bulk offered by Siegfried AG

    Find a price of Bismuth Subsalicylate bulk offered by Siegfried AG

    Find a price of Candeptin bulk offered by Siegfried AG

    Find a price of Cascara bulk offered by Siegfried AG

    Find a price of Clopidogrel bulk offered by Siegfried AG

    Find a price of Codeine bulk offered by Siegfried AG

    Find a price of Codeine Sulfate bulk offered by Siegfried AG

    Find a price of Cyproheptadine Hydrochloride bulk offered by Siegfried AG

    Find a price of Deserpidine bulk offered by Siegfried AG

    Find a price of Desvenlafaxine Succinate bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene HCl bulk offered by Siegfried AG

    Find a price of Dibenzosuberenone bulk offered by Siegfried AG

    Find a price of Dibenzsuberone bulk offered by Siegfried AG

    Find a price of Dihydrocodeine Tartrate bulk offered by Siegfried AG

    Find a price of Diltiazem Hydrochloride bulk offered by Siegfried AG

    Find a price of Diphenoxylate Hydrochloride bulk offered by Siegfried AG

    Find a price of Divalproex Sodium bulk offered by Siegfried AG

    Find a price of Gemfibrozil bulk offered by Siegfried AG

    Find a price of Glycopyrronium Bromide bulk offered by Siegfried AG

    Find a price of Gramicidin bulk offered by Siegfried AG

    Find a price of Hydralazine Hydrochloride bulk offered by Siegfried AG

    Find a price of Hydroxyzine Dihydrochloride bulk offered by Siegfried AG

    Find a price of Inositol niacinate bulk offered by Siegfried AG

    Find a price of Irbesartan bulk offered by Siegfried AG

    Find a price of Isoxsuprine Hydrochloride bulk offered by Siegfried AG

    Find a price of Khellin bulk offered by Siegfried AG

    Find a price of Mephenoxalone bulk offered by Siegfried AG

    Find a price of Mephobarbital bulk offered by Siegfried AG

    Find a price of Methacholine Chloride bulk offered by Siegfried AG

    Find a price of Metoprolol Tartrate bulk offered by Siegfried AG

    Find a price of Morphine Sulfate bulk offered by Siegfried AG

    Find a price of Narphen bulk offered by Siegfried AG

    Find a price of Neomycin bulk offered by Siegfried AG

    Find a price of Neomycin Sulfate bulk offered by Siegfried AG

    Find a price of Nimodipine bulk offered by Siegfried AG

    Find a price of Nitrendipine bulk offered by Siegfried AG

    Find a price of Omoconazole bulk offered by Siegfried AG

    Find a price of Oxcarbazepine bulk offered by Siegfried AG

    Find a price of Oxycodone Terephthalate bulk offered by Siegfried AG

    Find a price of Oxymorphone Hydrochloride bulk offered by Siegfried AG

    Find a price of Pethidine Hydrochloride bulk offered by Siegfried AG

    Find a price of Phenazopyridine bulk offered by Siegfried AG

    Find a price of Phenprobamate bulk offered by Siegfried AG

    Find a price of Pholcodine bulk offered by Siegfried AG

    Find a price of Propafenone Hydrochloride bulk offered by Siegfried AG

    Find a price of Propoxyphene Napsylate bulk offered by Siegfried AG

    Find a price of Quercetin bulk offered by Siegfried AG

    Find a price of Rescinnamine bulk offered by Siegfried AG

    Find a price of Reserpine bulk offered by Siegfried AG

    Find a price of Rutin bulk offered by Siegfried AG

    Find a price of Secobarbital Sodium bulk offered by Siegfried AG

    Find a price of Sodium Valproate bulk offered by Siegfried AG

    Find a price of Sulfiram bulk offered by Siegfried AG

    Find a price of Triamterene bulk offered by Siegfried AG

    Find a price of Tyrothricin bulk offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk offered by Siegfried AG

    Find a price of Xipamide bulk offered by Siegfried AG

    Find a price of VERABORE--SPECIAL AMORPHOUS ALKALOIDS OF VERATRUM VIRIDE bulk offered by Siegfried AG

    Find a price of AMMOIDIN (8-METHOXYPSORALEN, XANTHATOXIN) bulk offered by Siegfried AG

    Find a price of ORGANIZATION MFG SITE BUILDING FACILITIES AND OPERATION OF FACTORY IN TAOYUAN TAIWAN ROC bulk offered by Siegfried AG

    Find a price of AQUEESTROL bulk offered by Siegfried AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TAIPEI, TAIWAN. bulk offered by Siegfried AG

    Find a price of N-ACETYL PROCAINAMIDE HCL bulk offered by Siegfried AG

    Find a price of UTERASE bulk offered by Siegfried AG

    Find a price of PHTHALAMAQUIN bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE SOLUTION bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE, 2% bulk offered by Siegfried AG

    Find a price of RAUSERFIA TABLETS bulk offered by Siegfried AG

    Find a price of PROTAVERATRINE bulk offered by Siegfried AG

    Find a price of Atropine Sulfate bulk offered by Siegfried AG

    Find a price of Cyclizine bulk offered by Siegfried AG

    Find a price of Cyclizine Hydrochloride bulk offered by Siegfried AG

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Siegfried AG

    Find a price of Metacaine bulk offered by Siegfried AG

    Find a price of Nalbuphine Hydrochloride bulk offered by Siegfried AG

    Find a price of Naltrexone Methobromide bulk offered by Siegfried AG

    Find a price of Nepafenac bulk offered by Siegfried AG

    Find a price of Phenobarbital Sodium bulk offered by Siegfried AG

    Find a price of Phentermine bulk offered by Siegfried AG

    Find a price of Pseudoephedrine bulk offered by Siegfried AG

    Find a price of Pseudoephedrine Sulfate bulk offered by Siegfried AG

    Find a price of Rimegepant Sulfate bulk offered by Siegfried AG

    Find a price of Travoprost bulk offered by Siegfried AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search